Titration is an important and critical step in dosing recombinant virus for gene therapy, We present a relatively fast, convenient, and sensitive method that allows for precise quantification of recombinant retrovirus. The method is based on PCR amplification of a foreign gene by the PRINS (primer in situ DNA synthesis) technique, The PRINS technique is based on the sequence-specific annealing of unlabeled oligonucleotide DNA in situ, This oligonucleotide operates as a primer for in situ chain elongation catalyzed by the Tag I polymerase, Using digoxygenin-labeled nucleotides as a substrate for chain elongation, the neo-synthetic DNA is labeled by an FITC-conjugated anti-digoxygenin antibody. To avoid the possibility of false positives, we amplified the puromycin-resistance gene, which is associated with the transgene in the same viral vector and is not normally present in mammalian cells, The retroviral titer was evaluated by counting fluorescein isothiocyanate-positive cells after PRINS labeling, while knowing the number of plated cells that were transduced with different amounts of viral supernatant, A comparable viral concentration of 1 x 10(7) infectious units/mL was found among the retroviruses.

Application of the primer in situ DNA synthesis (PRINS) technique to titer recombinant virus and evaluation of the efficiency of viral transduction

Cinti C Cinti C;
2001

Abstract

Titration is an important and critical step in dosing recombinant virus for gene therapy, We present a relatively fast, convenient, and sensitive method that allows for precise quantification of recombinant retrovirus. The method is based on PCR amplification of a foreign gene by the PRINS (primer in situ DNA synthesis) technique, The PRINS technique is based on the sequence-specific annealing of unlabeled oligonucleotide DNA in situ, This oligonucleotide operates as a primer for in situ chain elongation catalyzed by the Tag I polymerase, Using digoxygenin-labeled nucleotides as a substrate for chain elongation, the neo-synthetic DNA is labeled by an FITC-conjugated anti-digoxygenin antibody. To avoid the possibility of false positives, we amplified the puromycin-resistance gene, which is associated with the transgene in the same viral vector and is not normally present in mammalian cells, The retroviral titer was evaluated by counting fluorescein isothiocyanate-positive cells after PRINS labeling, while knowing the number of plated cells that were transduced with different amounts of viral supernatant, A comparable viral concentration of 1 x 10(7) infectious units/mL was found among the retroviruses.
2001
Istituto di Fisiologia Clinica - IFC
PRINS; retinoblastoma; Rb2/p130; retrovirus; gene therapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/212825
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 4
social impact